Table 2 Patient demographics and baseline characteristics between group A and group C and between group B and group D
Factors | > 4 weeks | ≤ 4 weeks | ||||
|---|---|---|---|---|---|---|
Group A | Group C | P value | Group B | Group D | P value | |
Sex (M/F) | 34/3 | 23/5 | 0.275 | 22/5 | 26/5 | 1.000 |
Age (years) | 40 (35–46.5) | 47.5 (37.5–56.5) | 0.035 | 42 (33–50) | 44 (35–60) | 0.435 |
ALT (U/L) | 88 (46.5–312) | 48 (23.25–75.75) | 0.004 | 77 (46–336) | 42.5 (25.25–89) | 0.005 |
AST (U/L) | 109 (68–173.5) | 73 (45.25–131.5) | 0.054 | 103 (68–147) | 65 (47.5–92) | 0.002 |
TBIL (mmol/L) | 486 (346–550.5) | 415 (85.25–488.5) | 0.043 | 381 (219–495) | 149 (75.75–306.75) | 0.000 |
PTA | 35 (25.5–40.5) | 40.5 (29.75–53) | 0.033 | 34 (31–47) | 44.5 (34.75–59.25) | 0.006 |
MELD | 78 (76.5–81) | 76 (73–78) | 0.006 | 77 (75–82) | 72 (67.75–76) | 0.000 |